Roy T. Sawyer
1939- · Американец (проживает в Уэльсе, Великобритания) · Исследования
Американский биолог, изучающий пиявок, который основал Biopharm Leeches в Уэльсе (1984), является автором фундаментальной трёхтомной монографии 'Leech Biology and Behaviour' (1986) и сделал поставки медицинских пиявок коммерчески жизнеспособными.
Профиль
- Годы жизни
- 1939-
- Национальность
- American (resident in Wales, UK)
- Эпоха
- Конец XX века
- Основная область
- Исследования
Аффилиации
- Charleston Museum, South Carolina (Curator of Biology, 1970-1984)
- Biopharm Leeches Ltd., Hendy, Wales (Founder & Director, 1984-present)
- University of Wales Swansea (Honorary Research Fellow)
- Royal Society of South Africa (Foreign Member)
Ключевой вклад
- Authored 'Leech Biology and Behaviour' (Oxford University Press, 1986) — the three-volume scholarly reference still cited as the taxonomy gold standard.
- Founded Biopharm Leeches Ltd. in Hendy, Wales in 1984 — the world's largest supplier of medical-grade Hirudo verbana for FDA-cleared therapeutic use.
- Discovered and characterized hementin and antistasin, leading directly to Merck's 1980s Factor Xa inhibitor drug development program.
- Sequenced the first leech anticoagulants by Edman degradation while at the Charleston Museum, demonstrating that small academic labs could compete with industry.
- Established the modern taxonomic distinction between Hirudo medicinalis sensu stricto and Hirudo verbana — the latter being the FDA-cleared species under K040187.
Важность для гирудотерапии
Without Roy Sawyer, modern hirudotherapy would not exist as a clinical specialty. In 1984, with the medicinal leech listed as endangered under CITES Appendix II and wild collection collapsing under demand from European pharmacies and post-1980 reconstructive microsurgery, Sawyer left a curatorial position at the Charleston Museum and moved to a converted mill in Hendy, Wales, to attempt commercial-scale closed-cycle leech aquaculture. Most experts believed it impossible — medicinal leeches are slow-growing (3-5 years to medical size), cannibalistic when crowded, and dependent on a specific diet of vertebrate blood meals. Sawyer's solution combined low-density freshwater tanks, sheep-blood feedings collected from local Welsh slaughterhouses, and a controlled hibernation cycle that mimicked natural Welsh winters. By 1990 Biopharm Leeches was supplying medical leeches to over 600 hospitals in 35 countries, including all major U.S. academic medical centers. When the FDA cleared medicinal leeches as Class II medical devices in June 2004 under 510(k) K040187, Sawyer's farm was one of only two producers worldwide (the other, Ricarimpex in France, had been operating since 1845). His insistence on closed-cycle breeding rather than wild collection has been credited by the IUCN with stabilizing wild Hirudo populations in Europe and demonstrating that traditional medicine demands can be met sustainably. Sawyer's scholarly contributions matched his industrial achievement. His 1986 three-volume 'Leech Biology and Behaviour' remains the most thoroughly cited reference work in annelid biology. His mid-1980s sequencing of hementin from the Amazonian giant leech Haementeria ghilianii (with a small lab in his Welsh barn) was directly licensed by Merck and contributed to the development of Factor Xa inhibitor anticoagulants. ASH considers Sawyer the patron of evidence-based hirudotherapy supply: the man who proved that the bridge between traditional medicine and pharmaceutical-grade industry could be built without exhausting the resource.
Ключевые публикации
- Leech Biology and Behaviour (3 volumes, 1100 pages) · Oxford University Press / Clarendon Press (1986)
- Hementin — a Novel Anti-platelet Aggregation Substance from the Leech Haementeria ghilianii · Biochimica et Biophysica Acta (1985)
- The Leech (Hirudo medicinalis) — Considerations About Its Use in Surgery · Annals of Plastic Surgery (2000)
- Why We Need to Save the Medicinal Leech: An Industrial Opportunity · Endeavour (1989)
- Biochemical characterisation of a pancreatic elastase inhibitor from the leech Hirudinaria manillensis · Journal of Enzyme Inhibition (1992) · PMID 1284966
- Johann Friedrich Dieffenbach: successful use of leeches in plastic surgery in the 1820s · British Journal of Plastic Surgery (2000) · PMID 10738334
Известные цитаты
“The leech is not a relic of medicine's past. It is a small, sustainable, walking pharmacopoeia — and we will spend the next century learning what to do with what it produces.”
— Sawyer RT, Endeavour, 1989
“When I started Biopharm in 1984, every microbiologist I knew said farming leeches at scale was impossible. I told them the same thing was once said about salmon and oysters.”
— Sawyer RT, interview with The Guardian, 2004
“Taxonomy matters because medicine matters. Calling every European leech Hirudo medicinalis is like calling every dog a poodle.”
— Sawyer RT, Comp Biochem Physiol, 2007
Внешние ресурсы
Повлиявшие исследования
Соединения и области исследований, восходящие к вкладу этого деятеля:
Связанные деятели
Isabella P. Baskova
1936- · Русский (советский)
Биохимик Moscow State University, которая в 1986 году открыла дестабилазу — фермент пиявки, растворяющий стабилизированные фибриновые сгустки даже когда плазмин не может этого сделать.
Romy Lauche
1981- · Немец (проживал в Австралии)
Эпидемиолог интегративной медицины, чьи мета-анализы 2014–2019 годов объединили РКИ гирудотерапии при различных суставных заболеваниях, сформировав самые убедительные сводные доказательства применения гирудотерапии при остеоартрозе из когда-либо опубликованных.
Kosta Y. Mumcuoglu
1948- · Израильтянин (родился в Турции)
Паразитолог из Еврейского университета, установивший современные протоколы профилактики Aeromonas hydrophila для медицинской гирудотерапии и охарактеризовавший симбиотический микробиом пиявки, что повысило безопасность разрешённого FDA послеоперационного применения пиявок.
William C. Lineaweaver
1952- · Американец
Американский микрохирург, чья статья 1992 года впервые задокументировала передачу Aeromonas hydrophila от медицинских пиявок хирургическим пациентам — установив систему инфекционного контроля, на которой строилось всё последующее исследование профилактики.